Altium Capital Management LP Eloxx Pharmaceuticals, Inc. Transaction History

Altium Capital Management LP

  • $188 Million
  • Q2 2024

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2021

Feb 14, 2022
SELL
$0.62 - $1.61 $693,160 - $1.8 Million
-1,118,000 Closed
0 $0
Q3 2021

Nov 17, 2021
BUY
$1.22 - $2.0 $122,215 - $200,354
100,177 Added 9.84%
1,118,000 $1.82 Million
Q3 2021

Nov 15, 2021
BUY
$1.22 - $2.0 $424,200 - $695,410
347,705 Added 51.89%
1,017,823 $1.47 Million
Q2 2021

Aug 13, 2021
BUY
$1.35 - $3.36 $904,659 - $2.25 Million
670,118 New
670,118 $1.33 Million

About Eloxx Pharmaceuticals, Inc.

ELOX Quotes by TradingView
  • Ticker ELOX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 86,656,200
  • Description
  • Eloxx Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, focuses on developing ribosome modulation for the treatment of rare and ultra-rare premature stop codon diseases. Its lead investigational drug product candidate is ELX-02, which is in Phase 2 clinical trial for the treatment of cystic fibrosis and nephropathic cystinosis p...
More about ELOX
Track This Portfolio

Track Altium Capital Management LP Portfolio

Follow Altium Capital Management LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Altium Capital Management LP, based on Form 13F filings with the SEC.

News

Stay updated on Altium Capital Management LP with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email